Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Androgenetic Alopecia Alopecia Hair Diseases Hypotrichosis Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Ain Shams Univeristy Faculty of medicine

Cairo, Abbasia, 11757, Egypt

Location contact

Faculty of medicine ain shams university Ain shams university

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Androgenetic Alopecia Grades 1-4

Exclusion criteria

blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Treatment and study plan

Plasma derived exosomes

Drug

Exosomes derived from patients' plasma, centrifuged at high speeds multiple times

Primary outcomes

Terminal to vellus hair ratio improvement

Time frame: One year

Counting the terminal and vellus hair counts and calculating the ratio, and comparing it between different study sessions and at follow-ups

Study contacts

Contact information is provided by the study sponsor or research team.

Dana Ashraf Maher, Assistant lecturer

CONTACT

[email protected]

+20 1225077011

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Evaluation of Intradermal Exosome Injection in Treatment of Male Androgenetic Alopecia: A Clinical and Immunohistochemical Study

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2027
First posted: Aug 8, 2025
Registry last updated: Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting